Over 1 million doses of Oxford-AstraZeneca vaccine part of 24 million doses country expects to receive within months
NAIROBI, Kenya — Kenya has received just over 1 million
doses of a COVID-19 vaccine in the first batch from the global COVAX initiative
that was created to ensure that low- and middle-income countries have fair
access to vaccines.
Some 1.02 million doses of the AstraZeneca-Oxford vaccine,
manufactured by the Serum Institute of India, arrived in Nairobi early
Wednesday, according to a joint statement from UNICEF, the World Health
Organization, international vaccine alliance GAVI and the Coalition for
Epidemic Preparedness Innovations.
Kenyan Health Minister Mutahi Kagwe expressed excitement and
optimism that the vaccines would help stop the spread of the coronavirus that
has forced the East African country to partially lock down its economy with
devastating consequences for many citizens.
“We have been fighting the pandemic with rubber bullets but
what we have acquired today is equivalent, metaphorically speaking, to bazookas
and machine guns,” Kagwe said.
The minister said the vaccines will be administered to some
400,000 medical workers and the rest will go to other frontline workers such as
teachers and police officers.
Many Kenyan public health care workers have been disgruntled
over the inadequate supply of personal protective equipment, and they say they
were never paid the allowances that the government promised them for the extra
work and risk while combating COVID-19.
Austine Oduor, an official with the Kenya Union of Clinical
Officers, said there is no palpable excitement from members of his union and
nurses who were forced by a court order to resume work last week after a 70-day
strike.
“What they really wanted was payment of the allowances,”
Oduor said. “ In fact, some are questioning whether the distribution will be
done fairly in a country where corruption is rampant.”
Kenya has more than 106,000 confirmed virus cases including
more than 1,800 deaths.
No comments:
Post a Comment